Centralized procurement in major provinces of stapler production: an average drop of over 80%, and the domestic market will face tremendous changes

(Summary description)A few days ago, Jiangsu Province completed the fourth round of procurement negotiations with the Medical Consumables Alliance. The products purchased by the alliance include dry film and staplers. According to the official negotiation results, the average drop of staplers reached 83.93%, and the highest drop was 96.29%.

A few days ago, Jiangsu Province completed the fourth round of procurement negotiations with the Medical Consumables Alliance. The products purchased by the alliance include dry film and staplers. According to the official negotiation results, the average drop of staplers reached 83.93%, and the highest drop was 96.29%.

Jiangsu is a leading province in the local pilot project for the centralized procurement of high-value medical consumables. It took coronary stents as the first shot, and then continued to expand to neurology, ophthalmology, orthopedics, general surgery and other categories. Currently, three rounds of belt purchases have been completed. .

The stapler is a clinically used device that replaces traditional manual sutures. The main working principle is to use titanium nails to break or anastomose tissues. Similar to a stapler, the product can be widely used in cardiothoracic surgery, gastrointestinal surgery, liver, gallbladder, spleen and pancreas. Surgery, general surgery, urology and other surgical fields. According to official statistics, there are a total of 112 registered stapler manufacturers on the Jiangsu platform, including 76 stapler companies, with an annual sales amount of about 1.3 billion yuan.

It is understood that because Jiangsu is one of the provinces with a large amount of stapler usage in China, and more than 70% of the country's stapler manufacturers are concentrated in the province, this centralized procurement is highly valued by the industry.

"From the perspective of cost accounting, the business at my doorstep is always the most cost-effective." At the gathering negotiation scene on the 30th, a business person told a reporter from the Science and Technology Innovation Board.

It is worth mentioning that there have been rumors in the market recently that following the first batch of vascular interventional, non-vascular interventional, pacemaker, and ophthalmological products, relevant departments have begun the second batch of national procurement of high-value medical consumables. Data collection and price monitoring mainly involve artificial hip joints, artificial knee joints, defibrillators, occluders, orthopedic materials, staplers and other varieties.

The first batch of national procurement of coronary stents for vascular interventions was completed in early November. This is also the first high-value medical consumable variety that has been purchased by the country. The market speculates that the next variety that may be purchased by the country or will be in manual Hip joints, artificial knee joints, defibrillators, occluders, orthopedic materials, and staplers are produced in several varieties.